More Evidence that GLP-1s May Reduce Risk of Vision-Robbing Eye Diseases

(MedPage Today) -- Patients taking GLP-1 receptor agonists (GLP-1RAs) had a lower likelihood of developing age-related macular degeneration (AMD) compared with patients using other glucose-lowering medications or lipid-lowering drugs, a large retrospective...
Source
MedPage Today
Opens original article in a new tab



